RT Journal Article
SR Electronic
T1 214 The KRAS<sup>G12D</sup>(ON) covalent tricomplex inhibitor RM-044 increases tumor antigen presentation and TCR repertoire diversity to promote anti-tumor immunity in a preclinical model of KRAS<sup>G12D</sup> mutant cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A242
OP A242
DO 10.1136/jitc-2023-SITC2023.0214
VO 11
IS Suppl 1
A1 Shifrin, Nataliya Tovbis
A1 Menard, Marie
A1 Courtney, Haley
A1 Ganesh, Swetha
A1 Kumamoto, Alice
A1 Seu, Lillian
A1 Smith, Jacqueline AM
A1 Quintana, Elsa
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A242.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.